RESUMEN
Different crystalline forms of the local anaesthetic mepivacaine hydrochloride (MH) were revealed by Fourier transform infrared spectroscopy (FT-IR), not by conventional differential scanning calorimetry (DSC). The existence of two polymorphic anhydrous modifications was discovered and further characterized by X-ray powder diffraction and thermal analysis: Form II, the commercial one, and the more stable Form I, obtained by re-crystallization from Form II. Two pseudopolymorphs were also obtained: Form III, a solvate crystallized from ethanol and Form IV, a solvate crystallized from methanol. Single crystal X-ray diffraction data for both solvates were collected and their structures were determined. Form II, metastable and monotropically related to Form I, generates through desolvation of Form III, very often present in industrial processing, where crystallization from ethanol solution is a common practice. For the sake of clarity, the presence of polymorphic forms should be reported in the drug master files of MH. However, since MH is readily water soluble, the observed polymorphism has no relevance to its typical clinical use as aqueous solutions.
Asunto(s)
Anestésicos Locales/química , Química Farmacéutica/métodos , Mepivacaína/química , Anestésicos Locales/análisis , Fenómenos Químicos , Química Física , Calor , Mepivacaína/análisis , Modelos Químicos , Modelos Moleculares , Modelos Estadísticos , Conformación Molecular , Solubilidad , Solventes , Espectroscopía Infrarroja por Transformada de Fourier/métodos , Temperatura , Termogravimetría , Difracción de Rayos XRESUMEN
Treatment of the cyclo-P3 complexes [(triphos)MP3] [triphos = 1,1,1-tris(diphenylphosphinomethyl)ethane; M = Co (1), Rh (2)] with stoichiometric amounts of [M'(CO)5(thf)]n+ (n = 0, M' = Cr, Mo, W; n = 1, M' = Re) and [W(CO)4(PPh3)(thf)] yields the compounds [[(triphos)M](mu,eta 3:1-P3) [M'(CO)5]] [M = Co; M' = Cr (3a), Mo (3b), W (3c). M = Rh; M' = W (4)], [[(triphos)Co](mu,eta 3:1-P3)[Re(CO5)]]BF4.C7H8 (5) and [[(triphos)Rh](mu,eta 3:1-P3)[W(CO)4PPh3]].2CH2Cl2 (6). The X-ray structures of 5 and 6 have been determined. Crystal data: 5, monoclinic space group P2(1)/n, a = 14.754(2) A, b = 24.886(4) A, c = 15.182(2) A, beta = 103.38(1) degrees, Z = 4; 6, monoclinic space group P2(1)/n, a = 14.872(3) A, b = 27.317(6) A, c = 16.992(4) A, beta = 111.75(5) degrees, Z = 4. The effects of eta 1 coordination on the MP3 core are discussed by comparing the MP3 skeletons in the above structures with those of the previously characterized bis and tris end-on adducts of organometallic fragments of 1. Variable temperature NMR data for the compounds provide evidence for fluxional processes in solution that may be interpreted as [(triphos)M] rotation about its C3 axis and [M'(CO)5] or [M'(CO)4PPh3] scrambling over the P3 cycle. The activation parameters of the fragment scrambling process are determined.